Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.

The aim of this study was to optimize, develop, characterize and evaluate a topical nanobigel (BG) formulation containing Berberine (BRB) that exhibits anti-melanogenic properties. The Berberine-loaded bigel (BRB@BG) formulation was prepared by homogenously mixing the optimized hydrogel and oleogel. BRB@BG was characterized and cytotoxicity study was conducted to evaluate its effects on murine skin melanoma B16F10 cell lines. The optimized BRB@BG exhibited uniform texture with nanometric size, desirable spreadability and extrudability, suitable for topical applications. Cytotoxicity studies revealed that BRB@BG had a lower IC value (4.84 μg/ml) on B16F10 cell lines compared with drug alone. In conclusion, the developed BRB@BG formulation showed good potential as safe and effective topical treatment for hyperpigmentation.